S&P 500
(-0.38%) 5 016.66 points
Dow Jones
(0.18%) 37 882 points
Nasdaq
(-0.47%) 15 584 points
Oil
(-2.80%) $79.64
Gas
(-3.52%) $1.921
Gold
(0.57%) $2 316.10
Silver
(0.12%) $26.69
Platinum
(1.64%) $963.75
USD/EUR
(-0.05%) $0.937
USD/NOK
(-0.15%) $11.08
USD/GBP
(0.08%) $0.801
USD/RUB
(-0.05%) $93.40

Realaus laiko atnaujinimai Meridian Bioscience Inc [VIVO]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Diagnostics & Research
Atnaujinta30 saus. 2023 @ 23:00

0.00% $ 33.97

Live Chart Being Loaded With Signals

Commentary (30 saus. 2023 @ 23:00):
Profile picture for Meridian Bioscience Inc

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide...

Stats
Šios dienos apimtis 5.63M
Vidutinė apimtis 686 607
Rinkos kapitalizacija 1.49B
EPS $0 ( 2023-05-04 )
Last Dividend $0.125 ( 2019-02-01 )
Next Dividend $0 ( N/A )
P/E 21.09
ATR14 $0.299 (0.88%)
Insider Trading
Date Person Action Amount type
2023-01-31 Williams Felicia Sell 10 274 Common Stock
2023-01-31 Williams Felicia Sell 12 000 Stock Option (Right to Buy)
2023-01-31 Williams Felicia Sell 8 740 Stock Option (Right to Buy)
2023-01-31 Williams Felicia Sell 17 205 Stock Option (Right to Buy)
2023-01-31 Williams Felicia Sell 5 796 Stock Option (Right to Buy)
INSIDER POWER
-88.83
Last 100 transactions
Buy: 118 571 | Sell: 1 534 678

Tūris Koreliacija

Ilgas: 0.42 (neutral)
Trumpas: 0.51 (weak)
Signal:(71.236) Neutral

Meridian Bioscience Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
TCAC0.987
TCACU0.946
GLAQ0.82
ENVIU0.819
10 Labiausiai neigiamai susiję koreliacijos
KRBP-0.99
RICO-0.904
ORTX-0.817

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Meridian Bioscience Inc Koreliacija - Valiuta/Žaliavos

The country flag 0.64
( weak )
The country flag 0.70
( moderate )
The country flag -0.76
( moderate negative )
The country flag 0.70
( moderate )
The country flag -0.70
( moderate negative )

Meridian Bioscience Inc Finansinės ataskaitos

Annual 2022
Pajamos: $333.02M
Bruto pelnas: $188.36M (56.56 %)
EPS: $0.960
FY 2022
Pajamos: $333.02M
Bruto pelnas: $188.36M (56.56 %)
EPS: $0.960
FY 2021
Pajamos: $317.90M
Bruto pelnas: $201.15M (63.27 %)
EPS: $1.650
FY 2020
Pajamos: $253.67M
Bruto pelnas: $156.25M (61.60 %)
EPS: $1.080

Financial Reports:

No articles found.

Meridian Bioscience Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Meridian Bioscience Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0.950 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.00678 1990-11-29
Last Dividend $0.125 2019-02-01
Next Dividend $0 N/A
Payout Date 2019-02-14
Next Payout Date N/A
# dividends 114 --
Total Paid Out $9.88 --
Avg. Dividend % Per Year 0.00% --
Score 2.53 --
Div. Sustainability Score 0.950
Div.Growth Potential Score 0
Div. Directional Score 0.115 --
Next Divdend (Est)
(2024-07-17)
$0 Estimate 0.00 %
Dividend Stability
0.17 Bad
Dividend Score
2.53
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
1990 $0 0.00%
1991 $0 0.00%
1992 $0 0.00%
1993 $0 0.00%
1994 $0 0.00%
1995 $0 0.00%
1996 $0 0.00%
1997 $0 0.00%
1998 $0 0.00%
1999 $0 0.00%
2000 $0 0.00%
2001 $0 0.00%
2002 $0 0.00%
2003 $0.160 3.50%
2004 $0.178 3.83%
2005 $0.213 2.70%
2006 $0.307 2.09%
2007 $0.434 2.63%
2008 $0.560 1.88%
2009 $0.680 2.60%
2010 $0.760 3.51%
2011 $0.760 3.21%
2012 $0.950 4.98%
2013 $0.570 2.75%
2014 $0.800 3.06%
2015 $0.800 4.88%
2016 $0.800 4.10%
2017 $0.500 2.80%
2018 $0.500 3.47%
2019 $0.125 0.74%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.1971.500-3.93-5.90[0 - 0.5]
returnOnAssetsTTM-0.05281.200-1.760-2.11[0 - 0.3]
returnOnEquityTTM-0.06811.500-1.867-2.80[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.560.8002.181.741[1 - 3]
quickRatioTTM1.4720.8006.054.84[0.8 - 2.5]
cashRatioTTM0.9431.5005.878.81[0.2 - 2]
debtRatioTTM0.0682-1.5008.86-10.00[0 - 0.6]
interestCoverageTTM-65.481.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM-0.008252.00-0.00275-0.00550[0 - 30]
freeCashFlowPerShareTTM-0.1482.00-0.0740-0.148[0 - 20]
debtEquityRatioTTM0.0914-1.5009.63-10.00[0 - 2.5]
grossProfitMarginTTM0.5341.0004.434.43[0.2 - 0.8]
operatingProfitMarginTTM-0.1971.000-5.93-5.93[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.01161.000-1.176-1.176[0.2 - 2]
assetTurnoverTTM0.2680.800-1.544-1.235[0.5 - 2]
Total Score0.950

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-61.831.000-6.350[1 - 100]
returnOnEquityTTM-0.06812.50-1.200-2.80[0.1 - 1.5]
freeCashFlowPerShareTTM-0.1482.00-0.0493-0.148[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.008252.00-0.00275-0.00550[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.5181.5003.220[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.002951.000-2.570[0.1 - 0.5]
Total Score-0.720

Meridian Bioscience Inc

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.